COMBACTE is one of the projects of the IMI’s New Drugs 4 Bad Bugs (ND4BB) programme which tackles the scientific, regulatory, and economic challenges of developing new antibiotics to combat antibiotic resistance in Europe.
This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115523, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
Marc Bonten, Universiteit Utrecht
Bruno Francois, University of Limoges
Herman Goossens, University of Antwerp
Stephan Harbarth, University of Geneva
Hasan Jafri, EFPIA
Odin Naderer, Glaxo Smith Kline
Seamus O’Brien, AstraZeneca
Nathalie Seigneuret, IMI - ND4BB